Autologous Adipose Cells Therapy

Description

Autologous Adipose Cell Therapy is a series of process designated to address the demerits of the traditional autologous fat grafting and dermal fillers, while enhancing the versatility and aesthetic outcomes. In this study, the goal is to evaluate the safety and efficacy of Autologous Adipose cell Therapy for skin rejuvenation and hair improvement in human application.

Conditions

Hair Loss/Baldness, Wrinkle Appearance, Volume, Fine Lines, Skin Elasticity, Hair Thinning, Skin Pigmentation, Skin Texture

Talk to us

Study Overview

On this page

Study Details

Study overview

Autologous Adipose Cell Therapy is a series of process designated to address the demerits of the traditional autologous fat grafting and dermal fillers, while enhancing the versatility and aesthetic outcomes. In this study, the goal is to evaluate the safety and efficacy of Autologous Adipose cell Therapy for skin rejuvenation and hair improvement in human application.

Autologous Adipose Cells Therapy

Autologous Adipose Cells Therapy

Condition
Hair Loss/Baldness
Intervention / Treatment

-

Contacts and Locations

Lewes

The Centre for Cosmetic Surgery & Medicine, Newark, Lewes, Delaware, United States, 19958

Newark

The Centre for Cosmetic Surgery & Medicine, Newark, Delaware, United States, 19713

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Outpatients who express interest in skin rejuvenation, and/or who are experiencing skin conditions, such as winkles, fine lines, loss of skin elasticity, skin pigmentation, scarring.
  • 2. Outpatients who are experiencing hair loss or hair thinning
  • 3. Provision of signed and dated informed consent form
  • 4. Clearly stated willingness to comply with all the procedures of the study and availability of the study
  • 5. Female and Male aged between 21 to 80 years old 6 Medical clearance by family doctor
  • 1. Pregnancy or lactation
  • 2. Known allergic reaction to components of cell culture media
  • 3. Chronic disease , e.g. cardiovascular disease, diabetes, chronic kidney disease, seizures
  • 4. Chronic infections, e.g. skin fungi infection, psoriasis
  • 5. Chronic wound healing
  • 6. Currently taking hormone therapy
  • 7. History of cancers and active cancers
  • 8. Viral infection, e.g. HIV, hepatitis B, influenza, coronaviruses.

Ages Eligible for Study

21 Years to 80 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

CERM INC.,

Dr. Abdollah M. Malekzadeh, MD, MD, PRINCIPAL_INVESTIGATOR, The Centre for Cosmetic Surgery & Medicine

Dr. Arun Kumar, PhD, STUDY_DIRECTOR, CERM INC.

Study Record Dates

2025-11-01